3 Spam-Free Article(s) Found
Article Searches
Core Biotech Buys #16: Taking Advantage Of Weakness To Add To Conviction Ideas https://seekingalpha.com/article/4176184-core-biotech-buys-16-taking-advantage-weakness-add-conviction-ideas?source=feed_all_articles May 22, 2018 - Recent weakness in the biotech sector is an opportunity to add to conviction holdings.My ¨Week in Review¨ blog post appears to have the makings of a permanent feature due to positive feedback received
Lucky Seven: Bio Struggles, Achaogen Breaks Key Support https://seekingalpha.com/article/4176031-lucky-seven-bio-struggles-achaogen-breaks-key-support?source=feed_all_articles May 21, 2018 - Achaogen breaks key support.Aimmune Therapeutics is a buy.Immune Design keeps its head above water.
Lucky Seven: Exelixis Bounces Back, Global Blood Therapeutics Bleeds https://seekingalpha.com/article/4175647-lucky-seven-exelixis-bounces-back-global-blood-therapeutics-bleeds?source=feed_all_articles May 19, 2018 - Immune Design and Viking Therapeutics are added to the win column.Exelixis makes up for its lost ground and is grounded on concrete support.As predicted, shares in Global Blood Therapeutics bled late

Pages: 1

Page 1
DeepLinks for Array BioPharma
ARRY - Google Finance https://www.google.com/finance?q=ARRY Industry related info and international coverage Summary News
ARRY - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=ARRY Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options